title: [Leukemia: A highly malignant disease].
authors: Universität Frankfurt, Institut für Pharmazeutische Biologie, Frankfurt am Main. Rolf.Marschalek@em.uni-frankfurt.de
authors: Rolf
authors: R
authors: Marschalek
authors: Ilse
authors: I
authors: Zündorf
authors: Theo
authors: T
authors: Dingermann
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D000069439:Dasatinib; D004195:Disease Models, Animal; D049672:History, 19th Century; D006801:Humans; D000068877:Imatinib Mesylate; D007938:Leukemia / Q000175:diagnosis / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000266:history / Q000473:pathology; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D013844:Thiazoles / Q000627:therapeutic use; D014212:Tretinoin / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D013844:Thiazoles; D014212:Tretinoin; D000068877:Imatinib Mesylate; C498826:nilotinib; D000069439:Dasatinib